GlassScriptPhysician profile
Marina Borukhow
NPI 1114222304
$5,851.15
in general payments reported to CMS, 2019-2025
33 companies · $1,477 in 2025
The $1,477 reported for 2025 was more than what 89% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $481 · 2022: $1,104 · 2023: $1,451 · 2024: $1,338 · 2025: $1,477.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,850 · Education: $417.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,849.68 |
| Education | $416.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $1,148.33 | 2023-2025 | Gemtesa, Myfembree, Orgovyx |
| Astellas Pharma US INC | $1,118.13 | 2021-2025 | Veozah, Xtandi, Myrbetriq |
| Antares Pharma, INC. | $865.00 | 2021-2025 | Xyosted, Nocdurna, Tlando |
| Evofem Biosciences, INC. | $365.99 | 2021-2025 | Phexxi, Solosec, Phexx |
| Urovant Sciences INC | $337.75 | 2021-2022 | |
| Urogen Pharma, INC. | $195.21 | 2025 | |
| Janssen Biotech, INC. | $176.73 | 2022-2024 | Erleada |
| Halozyme INC | $167.48 | 2023 | |
| Dentsply Ih Ab | $148.28 | 2023-2025 | Lofric, Lofric |
| Tolmar, INC. | $141.95 | 2023-2024 | |
| Pfizer INC. | $133.88 | 2021 | |
| Endo Pharmaceuticals INC. | $118.22 | 2021-2024 | Xiaflex, Aveed |
| Abbvie INC. | $116.32 | 2024-2025 | |
| Acerus Pharmaceuticals Corporation | $116.32 | 2021-2022 | |
| Myovant Sciences INC. | $113.11 | 2021-2022 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo USA, INC. | $112.69 | 2024-2025 | Xiaflex, Aveed |
| Agile Therapeutics, INC. | $57.96 | 2021-2024 | Twirla |
| Hologic Sales and Service, LLC | $44.80 | 2025 | Novasure, Aptima |
| Therapeuticsmd, INC. | $42.57 | 2022 | |
| Mayne Pharma Commercial LLC | $36.14 | 2022 | |
| Terumo Medical Corporation | $35.61 | 2024 | Glidewire, Glidesheath Slender, Azur Cx Detachable |
| Novo Nordisk INC | $28.27 | 2025 | Rivfloza |
| Coloplast Corp | $26.41 | 2023 | Speedicath |
| Daiichi Sankyo INC. | $23.83 | 2022 | |
| Allergan, INC. | $23.54 | 2021 | |
| Millicent US INC | $23.32 | 2024 | Femring, Intrarosa |
| Progenics Pharmaceuticals, INC. | $23.17 | 2022 | |
| Boston Scientific Corporation | $21.25 | 2023 | Varithena Administration Pack |
| Lilly USA, LLC | $20.42 | 2025 | Zepbound |
| Organon LLC | $18.32 | 2023 | Nexplanon |
| Myriad Genetic Laboratories, INC. | $18.22 | 2023 | Prolaris |
| Avion Pharmaceuticals | $16.15 | 2023 | Balcoltra |
| Teleflex LLC | $15.78 | 2025 | Barrigel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marina Borukhow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.